Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 15 studies | 43% ± 23% | |
| epithelial cell | 4 studies | 48% ± 30% | |
| pancreatic A cell | 4 studies | 47% ± 13% | |
| type B pancreatic cell | 4 studies | 37% ± 11% | |
| respiratory goblet cell | 3 studies | 20% ± 2% | |
| secretory cell | 3 studies | 32% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 93% | 71.39 | 304 / 328 | 41% | 33.57 | 73 / 178 |
| ovary | 8% | 15.97 | 15 / 180 | 92% | 568.55 | 397 / 430 |
| breast | 61% | 400.30 | 278 / 459 | 40% | 189.13 | 448 / 1118 |
| prostate | 74% | 74.54 | 181 / 245 | 12% | 5.69 | 61 / 502 |
| thymus | 63% | 36.54 | 414 / 653 | 10% | 5.15 | 62 / 605 |
| stomach | 69% | 116.99 | 246 / 359 | 5% | 2.45 | 13 / 286 |
| skin | 57% | 79.97 | 1040 / 1809 | 0% | 0 | 0 / 472 |
| uterus | 34% | 510.26 | 58 / 170 | 21% | 174.16 | 98 / 459 |
| kidney | 51% | 19.52 | 45 / 89 | 5% | 5.72 | 44 / 901 |
| lung | 35% | 27.82 | 205 / 578 | 8% | 9.87 | 93 / 1155 |
| intestine | 33% | 32.00 | 314 / 966 | 6% | 4.42 | 29 / 527 |
| esophagus | 9% | 16.49 | 128 / 1445 | 2% | 1.80 | 4 / 183 |
| bladder | 5% | 4.62 | 1 / 21 | 2% | 1.85 | 10 / 504 |
| brain | 4% | 2.02 | 112 / 2642 | 0% | 0.21 | 2 / 705 |
| liver | 1% | 0.21 | 2 / 226 | 2% | 1.21 | 8 / 406 |
| adipose | 2% | 2.52 | 26 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.09 | 1 / 258 | 1% | 4.96 | 3 / 230 |
| muscle | 0% | 0.08 | 2 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.07 | 3 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 1.27 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.17 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030521 | Biological process | androgen receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SCGB2A1 |
| Protein name | Mammaglobin-B (Lacryglobin) (Lipophilin-C) (Mammaglobin-2) (Secretoglobin family 2A member 1) |
| Synonyms | UGB3 LIPHC MGB2 |
| Description | FUNCTION: May bind androgens and other steroids, may also bind estramustine, a chemotherapeutic agent used for prostate cancer. May be under transcriptional regulation of steroid hormones. |
| Accessions | ENST00000244930.6 O75556 |